PGY2 Pharmacy Residency Program Nuclear Pharmacy
Nuclear Pharmacy seeks to improve and promote the public health through the safe and effective use of radioactive drugs for diagnosis and therapy. A nuclear pharmacist, as a member of the nuclear medicine team, specializes in the procurement, compounding, quality control testing, dispensing, distribution, and monitoring of radiopharmaceuticals. In addition, the nuclear pharmacist provides consultation regarding health and safety issues, as well as the use of non-radioactive drugs and patient care.
WRNMMC Nuclear Pharmacy PGY2 Residency Program
The Walter Reed National Military Medical Center (WRNMMC) PGY2 Nuclear Pharmacy Residency Program is part of the National Capital Consortium and is designed to serve as a 12 month, post-graduate training program in nuclear pharmacy.
Walter Reed National Military Medical Center located in Bethesda, Maryland is the largest medical center in the Department of Defense and is accredited by The Joint Commission. Walter Reed Bethesda leads military medicine through outstanding patient-centered care, innovation, and excellence in education and research. We provide comprehensive care to prevent disease, restore health and maximize readiness proudly caring for our nations warriors and their families.
Walter Reed Bethesda is part of the National Capital Consortium (NCC). The NCC encompasses more than 62 Graduate Medical Education and affiliated programs and has numerous civilian training partnerships. Our medical campus s located across the street from the National Institutes of Health (NIH) and the National Library of Medicine (NLM) providing staff and trainee access to exceptional resources. On campus partners includes the F. Hebert School of Medicine of the Uniformed Services University of the Health Sciences (USUHS) and Armed Forces Radiobiology Research Institute (AFRRI).
The WRNMMC PGY2 Nuclear Pharmacy Residency Program prepares the resident for independent practice as a clinical nuclear pharmacy specialist. Pharmacists completing the residency will be competent and confident leaders and clinical practitioners equipped to meet the challenges of current and future nuclear pharmacy practice in support of nuclear medicine/molecular imaging services.
Upon completion of the residency, the pharmacist will meet the Nuclear Regulatory Commission (NRC) requirements for “Authorized Nuclear Pharmacist” (ANP) status and qualifies the resident for 2,000 hours towards the minimum 4,000 required hours for the Board of Pharmaceutical Specialties (BPS) Board Certification in Nuclear Pharmacy (BCNP).
Graduates of this program will be assigned as the radiopharmacist-in-charge of a radiopharmacy at one of the Army’s Medical Centers.
The WRNMMC PGY2 Nuclear Pharmacy Residency program is accredited by the American Society of Health-System Pharmacists (ASHP).
Special Requirements for Acceptance
Residents are selected from Army officers currently successfully serving on active duty. Prospective applicants must interview with the Residency Program Director and obtain the concurrence of the Army Pharmacy Consultant to the Army Surgeon General in addition to meeting the requirements outlined in the annual MILPER message and submitting a Long Term Health Education and Training (LTHET) board packet.
Program does not currently accept civilian residents and does not participate in the ASHP match. This practice is currently under review and may change in future years.